ProfileGDS4718 / 216570_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 81% 87% 83% 86% 90% 93% 85% 84% 87% 87% 83% 90% 91% 92% 90% 88% 90% 95% 92% 86% 85% 86% 88% 87% 93% 86% 91% 84% 90% 93% 92% 78% 84% 92% 93% 91% 85% 85% 87% 87% 93% 90% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6148886
GSM549102patient 115, normal, homogenized [OPG study]7.9114181
GSM549104patient 119, normal, homogenized [OPG study]8.8088887
GSM549108patient 138, normal, homogenized [OPG study]8.1452983
GSM549119patient 077, normal, homogenized [OPG study]8.4973586
GSM549133patient 032, cancer, homogenized [OPG study]9.3544290
GSM549139patient 042, cancer, homogenized [OPG study]9.6688293
GSM549099patient 107, normal, homogenized [OPG study]8.3968385
GSM549109patient 139, normal, homogenized [OPG study]8.2952284
GSM549110patient 046, normal, homogenized [OPG study]8.7059187
GSM549114patient 063, normal, homogenized [OPG study]8.882787
GSM549122patient 082, normal, homogenized [OPG study]8.2601683
GSM549134patient 033, cancer, homogenized [OPG study]9.2745290
GSM549136patient 036, cancer, homogenized [OPG study]9.4676291
GSM549140patient 044, cancer, homogenized [OPG study]9.5049392
GSM549111patient 047, normal, homogenized [OPG study]9.2158990
GSM549113patient 057, normal, homogenized [OPG study]9.0941988
GSM549132patient 031, cancer, homogenized [OPG study]9.2347990
GSM549137patient 038, cancer, homogenized [OPG study]10.089595
GSM549142patient 047, cancer, homogenized [OPG study]9.0679692
GSM549100patient 110, normal, homogenized [OPG study]8.5635886
GSM549107patient 135, normal, homogenized [OPG study]8.5115785
GSM549115patient 068, normal, homogenized [OPG study]8.7356986
GSM549116patient 072, normal, homogenized [OPG study]8.9851988
GSM549120patient 078, normal, homogenized [OPG study]8.7313487
GSM549131patient 030, cancer, homogenized [OPG study]9.7287393
GSM549118patient 074, normal, homogenized [OPG study]8.5957586
GSM549129patient 027, cancer, homogenized [OPG study]9.2400391
GSM549123patient 088, normal, homogenized [OPG study]8.3720884
GSM549124patient 006, cancer, homogenized [OPG study]9.0956390
GSM549126patient 015, cancer, homogenized [OPG study]9.6980293
GSM549128patient 025, cancer, homogenized [OPG study]9.5656492
GSM549103patient 117, normal, homogenized [OPG study]7.4811778
GSM549117patient 073, normal, homogenized [OPG study]8.3711584
GSM549138patient 041, cancer, homogenized [OPG study]9.5992792
GSM549141patient 045, cancer, homogenized [OPG study]9.7872993
GSM549130patient 028, cancer, homogenized [OPG study]9.3258691
GSM549101patient 111, normal, homogenized [OPG study]8.4546685
GSM549105patient 128, normal, homogenized [OPG study]8.4604285
GSM549106patient 134, normal, homogenized [OPG study]8.8815687
GSM549112patient 048, normal, homogenized [OPG study]8.7165687
GSM549125patient 011, cancer, homogenized [OPG study]9.6715893
GSM549127patient 024, cancer, homogenized [OPG study]9.1549690
GSM549135patient 035, cancer, homogenized [OPG study]9.8229293